IOM Plans Study To Facilitate Clinical Trial Data Sharing-thegraysheet: Clinical trials investigating devices, drugs, procedures and other interventions generate vast amounts of data. A subset of that data may be published in a journal, and more of it will sit behind closed doors at FDA or other government agencies and with the trial sponsor, but much of it is not available to other researchers or the public. There is a strong push for more data transparency in the health care community, although industry tends to be cautious about the idea, citing concerns about the release of trade secrets and the potential misuse of data.
